BEAM
Price:
$34.14
Market Cap:
$3.51B
Beam Therapeutics Inc., founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. Its core mission involves engineering precise genetic remedies to tackle a spectrum of severe human ailments, primarily within the United States. The company's developmental portfolio features several key candidates: BEAM-101 is being advanced to treat both sickle cell disease and beta thalassemia. BEAM-102 is specifically designed for addressing sickle cell disease. BEAM-201, an allogeneic chimeric antigen receptor T-cell therapy, is under investigation for individuals suffering from relapsed or refractory T-cell acute lymphoblastic leukemia. BEAM-301 is a liver-ta...[Read more]
Industry
Biotechnology
IPO Date
2020-02-06
Stock Exchange
NASDAQ
Ticker
BEAM
According to Beam Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -69.67. This represents a change of 1.98% compared to the average of -3.35 of the last 4 quarters.
The mean historical PE Ratio of Beam Therapeutics Inc. over the last ten years is -15.76. The current -69.67 PE Ratio has changed 44.11% with respect to the historical average. Over the past ten years (40 quarters), BEAM's PE Ratio was at its highest in in the December 2023 quarter at 3.84. The PE Ratio was at its lowest in in the September 2021 quarter at -51.79.
Average
-15.76
Median
-13.81
Minimum
-34.22
Maximum
-5.41
Discovering the peaks and valleys of Beam Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 532.01%
Maximum Annual PE Ratio = -5.41
Minimum Annual Increase = -81.10%
Minimum Annual PE Ratio = -34.22
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -34.22 | 532.01% |
| 2024 | -5.41 | -65.78% |
| 2023 | -15.83 | 67.12% |
| 2022 | -9.47 | -31.43% |
| 2021 | -13.81 | -7.13% |
| 2020 | -14.87 | 21.34% |
| 2019 | -12.25 | 114.38% |
| 2018 | -5.72 | -81.10% |
The current PE Ratio of Beam Therapeutics Inc. (BEAM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-18.49
5-year avg
-15.75
10-year avg
-15.76
Beam Therapeutics Inc.’s PE Ratio is less than Agios Pharmaceuticals, Inc. (-4.71), less than Denali Therapeutics Inc. (-8.09), less than Recursion Pharmaceuticals, Inc. (-2.69), less than ImmunityBio, Inc. (-8.62), less than Arcus Biosciences, Inc. (-7.68), less than 89bio, Inc. (-7.78), less than Cogent Biosciences, Inc. (-11.21), less than Mineralys Therapeutics, Inc. (-12.01), less than IDEAYA Biosciences, Inc. (-19.77), less than Galapagos N.V. (3.32),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.71 | $2.03B | |
| -8.09 | $3.70B | |
| -2.69 | $1.44B | |
| -8.62 | $7.71B | |
| -7.68 | $2.45B | |
| -7.78 | $2.20B | |
| -11.21 | $5.90B | |
| -12.01 | $1.63B | |
| -19.77 | $2.95B | |
| 3.32 | $1.84B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beam Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Beam Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Beam Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Beam Therapeutics Inc. (BEAM)?
What is the highest PE Ratio for Beam Therapeutics Inc. (BEAM)?
What is the 3-year average PE Ratio for Beam Therapeutics Inc. (BEAM)?
What is the 5-year average PE Ratio for Beam Therapeutics Inc. (BEAM)?
How does the current PE Ratio for Beam Therapeutics Inc. (BEAM) compare to its historical average?